Resultados de la búsqueda 51-60 of 2656 for Inhibition

  1. Hematología - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Olaparib is an inhibitor of PARP, an enzyme that helps repair ... PARP inhibitors are a type of targeted therapy. Adding abemaciclib to ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Olaparib is an inhibitor of PARP, an enzyme that helps repair ... PARP inhibitors are a type of targeted therapy. Adding abemaciclib to ...

  4. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate ALPN-202 with PD-1 inhibition to treat adults with advanced solid tumors or lymphoma. GENetic Risk Estimation of ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I trial is looking to see if sargramostim given with a nebulizer, in combination with standard immune checkpoint inhibitor therapy with nivolumab can ...

  6. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    ... inhibitors treatments, have been unsuccessful or not well tolerated, and the patient has a GFR ≥ 45 ml/min/1.73m2, or the patient is post renal transplantation ...

  7. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    ... inhibitors treatments, have been unsuccessful or not well tolerated, and the patient has a GFR ≥ 45 ml/min/1.73m2, or the patient is post renal transplantation ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...